![Ivor MacLeod](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivor MacLeod
No open positions remaining
Net worth: 315 698 $ as of 30/08/2026
Profile
Mr. Ivor MacLeod was previously employed as a Chief Financial & AccoutingOfficer by SCYNEXIS, Inc., a Chief Financial & Accounting Officer by Athersys, Inc., a Chief Financial & Compliance Officer, SVP by Eisai, Inc., a Vice President-Finance by Merck & Co., Inc., and a Chief Financial Officer-North America by Hoffmann-La Roche, Inc. He received his undergraduate degree from the University of St. Andrews and an MBA from Eller College of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCYNEXIS, INC. 0.61% | 31/03/2026 | 60,363 ( 0.61% ) | 315 698 $ | 30/08/2026 |
Former positions of Ivor MacLeod
| Companies | Position | End |
|---|---|---|
| SCYNEXIS, INC. | Director of Finance/CFO | 08/09/2026 |
| ATHERSYS, INC. | Director of Finance/CFO | 29/06/2022 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Director of Finance/CFO | 31/12/2017 |
| MERCK & CO., INC. | Director of Finance/CFO | 31/12/2014 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Director of Finance/CFO | - |
Training of Ivor MacLeod
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University of St. Andrews
 University of St. Andrews Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Eller College of Management
 Eller College of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Ivor MacLeod
